Elizabeth Humes

ORCID: 0000-0003-3432-7688
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • HIV-related health complications and treatments
  • LGBTQ Health, Identity, and Policy
  • Sexuality, Behavior, and Technology
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Sex work and related issues
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Food Security and Health in Diverse Populations
  • Syphilis Diagnosis and Treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Homelessness and Social Issues
  • Reproductive tract infections research
  • COVID-19 Impact on Reproduction
  • Herpesvirus Infections and Treatments
  • Viral-associated cancers and disorders
  • Intimate Partner and Family Violence
  • Bartonella species infections research
  • Machine Learning in Healthcare
  • Hepatitis Viruses Studies and Epidemiology
  • Chronic Disease Management Strategies
  • Health and Lifestyle Studies
  • Advanced Causal Inference Techniques

Johns Hopkins University
2019-2024

University of Colorado Anschutz Medical Campus
2021

University of Colorado Denver
2021

University of Colorado Hospital
2021

California State University, Long Beach
2020

Yale University
2015-2019

University of Washington
2019

University of Alabama at Birmingham
2019

Baltimore City Health Department
2017-2018

Eunice Kennedy Shriver National Institute of Child Health and Human Development
2013

<h3>Importance</h3> Recommendations for additional doses of COVID-19 vaccines people with HIV (PWH) are restricted to those advanced disease or unsuppressed viral load. Understanding SARS-CoV-2 infection risk after vaccination among PWH is essential informing guidelines. <h3>Objective</h3> To estimate the rate and breakthrough infections fully vaccinated without (PWoH) in United States. <h3>Design, Setting, Participants</h3> This cohort study used Corona-Infectious-Virus Epidemiology Team...

10.1001/jamanetworkopen.2022.15934 article EN cc-by-nc-nd JAMA Network Open 2022-06-07

Understanding how complex networks of genes integrate to produce dividing cells is an important goal that limited by the difficulty in defining function individual genes. Current resources for systematic identification gene such as siRNA libraries and collections deletion strains are costly organism specific. We describe here integration profiling, a novel approach identify eukaryotic based upon dense maps transposon integration. As proof concept, we used Hermes generate library 360,513...

10.1534/genetics.113.152744 article EN Genetics 2013-07-27

Understanding advances in the care and treatment of adults with HIV as well remaining gaps requires comparing differences mortality between persons entering for general population.To assess extent to which among United States is elevated over matched U.S. population trends this difference time.Observational cohort study.Thirteen sites from North American AIDS Cohort Collaboration on Research Design.82 766 clinical 1999 2017 a subset calendar time, age, sex, race/ethnicity, county using data...

10.7326/m21-0065 article EN Annals of Internal Medicine 2021-07-05

Understanding the severity of postvaccination SARS-CoV-2 (ie, COVID-19) breakthrough illness among people with HIV (PWH) can inform vaccine guidelines and risk-reduction recommendations.To estimate rate risk severe vaccinated PWH without (PWoH) who experience a infection.In this cohort study, Corona-Infectious-Virus Epidemiology Team (CIVET-II) collaboration included adults (aged ≥18 years) were receiving care fully by June 30, 2021, along PWoH matched according to date vaccinated, age...

10.1001/jamanetworkopen.2022.36397 article EN cc-by-nc-nd JAMA Network Open 2022-10-13

10.1016/s2352-3018(18)30360-6 article EN The Lancet HIV 2019-02-27

Objective: To project the future age distribution of people with HIV using antiretroviral therapy (ART) in United States, under expected trends diagnosis and survival (baseline scenario) achieving ending epidemic (EHE) goals a 75% reduction diagnoses from 2020 to 2025 sustaining levels 2030 (EHE75% scenario). Design: An agent-based simulation model mathematical functions estimated North American AIDS Cohort Collaboration on Research Design data parameters US Centers for Disease Control...

10.1097/qad.0000000000003128 article EN AIDS 2021-11-08

Improvements in life expectancy among people living with human immunodeficiency virus (PLWH) receiving antiretroviral treatment the United States and Canada might differ key populations. Given difference substance use populations current opioid epidemic, drug- alcohol-related deaths be contributing to disparities expectancy. We sought estimate at age 20 years (and their comparison groups) 3 time periods (2004-2007, 2008-2011, 2012-2015) potential increase expected a simulated 20% reduction...

10.1093/aje/kwz232 article EN cc-by-nc American Journal of Epidemiology 2019-10-02

Foodborne pathogens cause >9 million illnesses annually. Food safety efforts address the entire food chain, but an essential strategy for preventing foodborne disease is educating consumers and preparers. To better understand epidemiology of to direct prevention efforts, we examined incidence Salmonella infection, Shiga toxin-producing Escherichia coli hemolytic uremic syndrome by census tract-level socioeconomic status (SES) in Connecticut Diseases Active Surveillance Network site...

10.3201/eid2109.150277 article EN cc-by Emerging infectious diseases 2015-07-10

The HIV epidemic disproportionately impacts transgender women in the United States. Cohort studies identify unique risks for affected populations, but use of facility-based methods may bias findings towards individuals living research catchment areas, more engaged health services, or, case those who are open about their identity. Digital clinical trials and other online increasingly common, providing opportunity to reach not commonly research. Simultaneously, there is a need understand...

10.2196/29152 article EN cc-by JMIR Research Protocols 2021-03-31

The release of the first drug for human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) in 2012 marked beginning a new era HIV prevention. Although PrEP is highly efficacious, identifying and ultimately increasing uptake among highest risk male subgroups remains challenge. Public health surveillance data from 2009 to 2016 was used evaluate an diagnosis after syphilis (ie, primary, secondary, or early latent), gonorrhea, repeat diagnoses urban males, including men who have sex...

10.1097/olq.0000000000000964 article EN cc-by-nc-nd Sexually Transmitted Diseases 2018-12-15
Kathleen A. McGinnis Amy C. Justice Richard D. Moore Michael J. Silverberg Keri N. Althoff and 90 more Maile Karris Viviane D. Lima Heidi M. Crane Michael A. Horberg Marina B. Klein Stephen J. Gange Kelly A. Gebo Ángel M. Mayor Janet P. Tate Constance A. Benson Ronald J. Bosch Gregory D. Kirk Vincent C. Marconi Jonathan Colasanti Kenneth H. Mayer Chris Grasso Robert S. Hogg Viviane D. Lima Julio Montaner Paul Sereda Kate Salters Kate Buchacz Jun Li Kelly A. Gebo Richard D. Moore Richard D. Moore Jeffrey M. Jacobson Michael A. Horberg Michael J. Silverberg Jennifer E. Thorne Todd T. Brown Phyllis C. Tien Gypsyamber D’Souza Graham Smith Mona Loutfy Meenakshi Gupta Marina B. Klein Charles S. Rabkin Abigail Kroch Ann N. Burchell Adrian Betts Joanne Lindsay Ank E. Nijhawan Ángel M. Mayor M. John Gill Jeffrey N. Martin Jun Li John T. Brooks Michael S. Saag Michael J. Mugavero James H. Willig Laura Bamford Maile Karris Joseph J. Eron Sonia Napravnik Mari M. Kitahata Heidi M. Crane Timothy R. Sterling David W. Haas Peter F. Rebeiro Megan Turner Kathleen A. McGinnis Amy C. Justice Richard D. Moore Keri N. Althoff Stephen J. Gange Mari M. Kitahata Jennifer Lee Michael S. Saag Michael A. Horberg Marina B. Klein Rosemary G. McKaig Aimee Freeman Richard D. Moore Keri N. Althoff Aimee Freeman Mari M. Kitahata Stephen E. Van Rompaey Heidi M. Crane Liz Morton Justin McReynolds William B. Lober Stephen J. Gange Jennifer Lee Brenna Hogan Bin You Elizabeth Humes Lucas Gerace Cameron Stewart Sally B. Coburn

Abstract Background The updated Veterans Aging Cohort Study (VACS) Index 2.0 combines general and human immunodeficiency virus (HIV)–specific biomarkers to generate a continuous score that accurately discriminates risk of mortality in diverse cohorts persons with HIV (PWH), but alone is difficult interpret. Using data from the North American AIDS Collaboration (NA-ACCORD), we translate VACS scores into validated probability estimates mortality. Methods Because complete ascertainment...

10.1093/cid/ciab883 article EN Clinical Infectious Diseases 2021-09-30

Recommendations for additional doses of COVID vaccine are restricted to people with HIV who have advanced disease or unsuppressed viral load. Understanding SARS-CoV-2 infection risk post-vaccination among PWH is essential informing vaccination guidelines.

10.1101/2021.12.02.21267182 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-12-06

Background. The introductions of the varicella vaccine in 1995 and herpes zoster (HZ) 2006 have an ongoing potential to modify epidemiology both diseases. Analysis data on hospitalizations can be conducted examine trends occurrence severe disease over time assess possible impact vaccination incidence hospitalization. Methods. Statewide hospital discharge 1994-2012 Connecticut were used identify individuals discharged with a diagnosis initial admissions persons HZ first or second diagnostic...

10.1093/ofid/ofv001 article EN cc-by-nc-nd Open Forum Infectious Diseases 2015-01-01

This study characterized arrest, incarceration, and risk factors for incident incarceration among transgender women (TW) in the northeastern southern United States. During semiannual visits over 24 months a multicenter cohort study, TW completed HIV testing self-administered surveys. In total, 1571 baseline survey; 1,312 HIV-negative enrolled contributed 2134.3 person-years to analysis. At baseline, 37% had been arrested 21% incarcerated. Incident was 23.4 per 1,000 (95% confidence interval...

10.1089/jchc.21.10.0118 article EN Journal of Correctional Health Care 2022-08-29

The age-distribution of men who have sex with (MSM) continues to change in the 'Treat-All' era as effective test-and-treat programs target key-populations. However, nature these changes and potential racial heterogeneities remain uncertain.

10.1016/j.annepidem.2021.08.021 article EN cc-by-nc-nd Annals of Epidemiology 2021-10-09

Background In the United States, transgender women are disproportionately impacted by HIV and prioritized in national strategy to end epidemic. Individual, interpersonal, structural vulnerabilities underlie acquisition among fuel syndemic conditions, yet no nationwide cohort monitors their other health outcomes. Objective Our objective is develop a estimate incidence, identify risk factors, investigate conditions co-occurring with vulnerability or US women. The study informed Syndemics...

10.2196/59846 article EN cc-by JMIR Research Protocols 2024-06-18

Background People with HIV (PWH) are at an increased risk of cardiovascular disease (CVD) unknown added impact hepatitis C virus (HCV) coinfection. We aimed to identify whether HCV coinfection increases the type 1 myocardial infarction (T1MI) and if differs by age. Methods Results used data from NA-ACCORD (North American AIDS Cohort Collaboration on Research Design) January 1, 2000, December 31, 2017, PWH (aged 40-79 years) who had initiated antiretroviral therapy. The primary outcome was...

10.1161/jaha.122.026473 article EN cc-by-nc-nd Journal of the American Heart Association 2022-09-21
Jennifer Lee Elizabeth Humes Brenna Hogan Kate Buchacz Joseph J. Eron and 93 more M. John Gill Timothy R. Sterling Peter F. Rebeiro Viviane D. Lima Ángel M. Mayor Michael J. Silverberg Michael A. Horberg Richard D. Moore Keri N. Althoff Constance A. Benson Ronald J. Bosch Gregory D Kirk Emory-Grady Kenneth H. Mayer Chris Grasso Robert S. Hogg P. Richard Harrigan Julio Montaner Benita Yip Julia Zhu Kate Salters Karyn Gabler Kate Buchacz Jun Li Kelly A. Gebo R Johns Richard D. Moore John T. Carey Benigno Rodríguez Michael A. Horberg Michael J. Silverberg Jennifer E. Thorne Todd T. Brown Phyllis C. Tien Gypsyamber D’Souza Frederic Crouzat Mona Loutfy Graham Smith Meenakshi Gupta Marina B. Klein Charles S. Rabkin Abigail Kroch Ann N. Burchell Adrian Betts Joanne Lindsay Ank E. Nijhawan Robert F. Hunter-Mellado Ángel M. Mayor M. John Gill Jeffrey N. Martin Jun Li John T. Brooks Michael S. Saag Michael J. Mugavero James H. Willig Laura Bamford Maile Karris Joseph J. Eron Sonia Napravnik Mari M. Kitahata Heidi M. Crane Timothy R. Sterling David M. Haas Peter F. Rebeiro Megan Turner Lesley S. Park Amy C. Justice Richard D. Moore Keri N. Althoff Stephen J. Gange Mari M. Kitahata Jennifer Lee Michael S. Saag Michael A. Horberg Marina B. Klein Rosemary G. McKaig Aimee Freeman Richard D. Moore Keri N. Althoff Aimee Freeman Mari M. Kitahata Stephen E. Van Rompaey Heidi M. Crane Liz Morton Justin McReynolds William B. Lober Stephen J. Gange Jennifer Lee Brenna Hogan Bin You Elizabeth Humes Lucas Gerace Cameron Stewart Sally B. Coburn

From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time antiretroviral therapy (ART) prescription declined from 69 6 days, CD4 count at entry into care increased 300 362 cells/μL, and ART 160 364 cells/μL.

10.1093/cid/ciaa1904 article EN Clinical Infectious Diseases 2020-12-24
Coming Soon ...